Treatment of athletes with cardiac disease or arrhythmias.

Treatment of athletes with cardiac disease or arrhythmias. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Treatment of athletes with cardiac disease or arrhythmias. Abstract Text:

Amil M Shah,N A Mark Estes Iii,Jonathan Weinstock,Munther K Homoud,Mark S Link,

Ventricular arrhythmias and sudden cardiac death in the athlete are uncommon but extremely visible because of the high profile of amateur and professional athletes. In athletes under the age of 30 years, the incidence of sudden death is low and in most cases occurs in individuals with inherited heart disease. In the older athlete, sudden death is more common and is generally due to arrhythmias in the context of coronary artery disease. Many athletes with aborted sudden death, arrhythmia-related syncope, or high-risk genetic disorders benefit from therapy with implantable cardioverter-defibrillators (ICDs). Although ICD therapy can effectively abort sudden death, implantation of an ICD generally prohibits an individual from all competitive athletics except low-intensity sports. Recommendations for participation in competitive athletics generally follow the recently published 36th Bethesda Conference Eligibility Recommendations for Competitive Athletes with Cardiovascular Abnormalities.

Treatment of athletes with cardiac disease or arrhythmias. Publishing Authors By Initials

AM Shah,NA Estes Iii,J Weinstock,MK Homoud,MS Link,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Treatment of athletes with cardiac disease or arrhythmias. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Current treatment options in cardiovascular medici

VOLUME: 8

Page Numbers: 353-61

Journal Abbreviation:

ISSN: 1092-8464

DAY: 30

MONTH: Sep

YEAR: 2006

Treatment of athletes with cardiac disease or arrhythmias. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9815942

Treatment of athletes with cardiac disease or arrhythmias. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Treatment of athletes with cardiac disease or arrhythmias. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Treatment of athletes with cardiac disease or arrhythmias.

AFFILIATION: Tufts-New England Medical Center, Cardiac Arrhythmia Service, Division of Cardiology, 750 Washington Street, Box # 197, Boston, MA 02111, USA. mlink@tufts-nemc.org.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Curr Treat Options Cardiovasc

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Treatment of athletes with cardiac disease or arrhythmias Related Publications

• "Smart dust": nanostructured devices in a grain of sand.
• Analyzing proteomes and protein function using graphical comparative analysis of tandem mass spectrometry results.
• Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100.
• C. elegans models of age-associated neurodegenerative diseases: lessons from transgenic worm models of Alzheimer's disease.
• Can we look forward to better anticoagulants than heparin and dicumarol?
• Chondroma and chondrosarcoma of the larynx.
• Commotio cordis.
• Concentrations of particulate matter in schools in southwest Germany.
• Decreased insulin-receptor signaling promotes the autophagic degradation of beta-amyloid peptide in C. elegans.
• Fuzzy logic structure analysis of trabecular bone of the calcaneus to estimate proximal femur fracture load and discriminate subjects with and without vertebral fractures using high-resolution magnetic resonance imaging at 1.5 T and 3 T.
• Hfq structure, function and ligand binding.
• Immunoglobulin abnormalities in cerebrospinal fluid and blood in children with febrile seizures.
• Interaction of intracellular beta amyloid peptide with chaperone proteins.
• Interkinetic nuclear migration and the selection of neurogenic cell divisions during vertebrate retinogenesis.
• Laparoscopic radical prostatectomy in obese patients: feasible or foolhardy?
• Lentiviral-mediated RNAi inhibition of Sbds in murine hematopoietic progenitors impairs their hematopoietic potential.
• MRI-derived T2 relaxation times and cartilage morphometry of the tibio-femoral joint in subjects with and without osteoarthritis during a 1-year follow-up.
• Mutations in laminin alpha 1 result in complex, lens-independent ocular phenotypes in zebrafish.
• Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis.
• Plague among wild rodents in Rio Arriba County, New Mexico.
• Regulation of systemic and local neutrophil responses by G-CSF during pulmonary Pseudomonas aeruginosa infection.
• Severe congenital neutropenia and the unfolded protein response.
• Some Factors Involved in the Use of Chloramines for the Disinfection of Swimming Pools.
• Suppression of in Vivo -Amyloid Peptide Toxicity by Overexpression of the HSP-16.2 Small Chaperone Protein.
• The disarrayed mutation results in cell cycle and neurogenesis defects during retinal development in zebrafish.
• The myotonic dystrophy type 2 protein ZNF9 is part of an ITAF complex that promotes cap-independent translation.
• Treatment of athletes with cardiac disease or arrhythmias.
• Underappreciated species in ecology: "ugly fish" in the northwest Atlantic Ocean.
• Volumetric cartilage measurements of porcine knee at 1.5-T and 3.0-T MR imaging: evaluation of precision and accuracy.
• [Not Available.]